Zetagen Therapeutics announces first patients enrolled in phase 2a clinical study of ZetaMet (Zeta-BC-003) for metastatic ...
MedPage Today on MSN3d
Upfront TKI for Bone-Predominant RCC Tops Single-Agent ImmunotherapyMedian overall survival (OS) increased from 19.3 months with upfront immune checkpoint inhibition (ICI) to 41.3 months when a ...
Fred Hutch Cancer Center brought together a host of experts on November 2 to share tips, tools, resources and strategies for ...
A woman whose cancer has spread to her bones, back, pelvis and neck but has been denied a life-extending drug because she ...
FRAX has been validated for fracture risk assessment for patients with cancer, with HRs indicating an association between ...
2d
A 41-year-old Dunwoody mom who never smoked a day in her life was diagnosed with terminal stage 4 lung cancer.
More people are getting cancer in their 20s, 30s, and 40s, and surviving, thanks to rapid advancement in care. Many will have ...
Intravenous; mCRPC: Metastatic castration-resistant prostate cancer; P: Placebo ... the incidence of skeletal-related events (SREs) in bone metastatic CRPC (mCRPC). Denosumab compared with ...
Racine County Eye on MSN3d
What is the New Cure for Prostate Cancer?Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer ...
News Medical on MSN4d
Researchers develop promising new genetic breast cancer modelA Michigan State University researcher's new model for studying breast cancer could help scientists better understand why and ...
Verywell Health on MSN1y
Lung Cancer Stages, Prognosis, and ProgressionMedically reviewed by Susan Russell, MDLung cancer prognosis tends to be better for people diagnosed in earlier stages of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback